Add Yahoo as a preferred source to see more of our stories on Google. Martin Makary, President Donald Trump's nominee to lead the Food and Drug Administration testifies during his confirmation hearing ...

Bionxt has completed manufacturing of a batch of BNT23001, its under-the-tongue formulation of cladribine, for use in MS ...

The Trump administration is redoubling its efforts to phase out animal testing in drug development and seeking to develop new biotechnology methods instead to spur innovation in the pharmaceutical ...

Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...

For generations, U.S. laboratories treated animal testing as an unquestioned prerequisite for new drugs and chemicals, even as the ethical toll mounted. Now, after centuries of routine cruelty, the ...